Urinary Urgency: What Could Be Causing It

Overactive Bladder Is the Most Common Cause

Overactive bladder syndrome accounts for the majority of isolated urinary urgency in adults who have no infection or anatomic obstruction. OAB is defined by the International Continence Society as "urgency, with or without urge incontinence, usually with increased daytime frequency and nocturia, in the absence of infection or other obvious pathology" [1]. The condition affects an estimated 16.5% of the U.S. adult population according to the NOBLE study (N=5,204), with prevalence rising sharply after age 40 [2].

OAB results from involuntary detrusor muscle contractions during bladder filling. The detrusor contracts when it should remain relaxed, generating the sudden, hard-to-suppress urge. Risk factors include aging, obesity (BMI ≥30), diabetes, and a history of recurrent urinary tract infections [3]. Women are more likely to experience the "wet" subtype (OAB with urge incontinence), while men more often report "dry" OAB (urgency and frequency without leakage).

The diagnosis is clinical. No specific test confirms OAB. Instead, clinicians arrive at the diagnosis after excluding infection via urinalysis, ruling out significant post-void residual urine (greater than 200 mL suggests obstruction or underactive detrusor), and confirming the absence of hematuria. A 3-day bladder diary recording fluid intake, void times, and urgency episodes helps quantify severity and guide treatment [1].

Dr. Victor Nitti, Professor of Urology at NYU Langone, has noted: "OAB is a diagnosis of exclusion. The single most important step is a good history. If the patient describes a sudden, compelling desire to void that is difficult to defer, and infection has been ruled out, you have your diagnosis" [4].

Urinary Tract Infections Cause Acute-Onset Urgency

A urinary tract infection should be the first consideration when urgency develops suddenly, especially when accompanied by dysuria (pain on urination) or suprapubic discomfort. UTIs cause irritation of the bladder mucosa, triggering detrusor contractions and the sensation of urgency even when the bladder holds very little urine.

Uncomplicated cystitis affects approximately 50 to 60% of women at least once during their lifetime [5]. Escherichia coli causes 75 to 95% of uncomplicated cases. Diagnosis requires a positive urine culture (≥10^3 colony-forming units/mL of a uropathogen in a symptomatic patient), though empiric treatment is often started based on symptoms plus a positive dipstick for leukocyte esterase or nitrites [6].

Short. That is how treatment should be. Uncomplicated cystitis in women responds to a 3-day course of trimethoprim-sulfamethoxazole or a 5-day course of nitrofurantoin [6]. If urgency persists beyond successful antibiotic treatment, the clinician should suspect an underlying condition such as OAB that was previously masked or a chronic inflammatory process like interstitial cystitis.

Recurrent UTIs (defined as two or more infections in six months or three or more in twelve months) deserve further workup, including imaging of the upper urinary tract and consideration of cystoscopy to evaluate for anatomic abnormalities or bladder pathology [5].

Benign Prostatic Hyperplasia in Men Over 50

In men, the prostate gland surrounds the proximal urethra. As it enlarges with age, it compresses the urethra and changes bladder dynamics. BPH affects roughly 50% of men aged 51 to 60 and up to 90% of men older than 80 [7]. Storage symptoms (urgency, frequency, nocturia) are often more bothersome to patients than obstructive symptoms (weak stream, hesitancy, incomplete emptying).

The mechanism linking BPH to urgency involves two pathways. Partial outlet obstruction forces the detrusor to generate higher pressures during voiding, leading to muscle hypertrophy and eventually detrusor overactivity. Simultaneously, prostatic tissue may directly irritate alpha-adrenergic receptors in the bladder neck and trigone area [7].

Evaluation includes the International Prostate Symptom Score (IPSS), digital rectal examination, serum PSA (to screen for prostate cancer), urinalysis, and measurement of post-void residual. An IPSS score of 8 to 19 indicates moderate symptoms; 20 or above indicates severe symptoms requiring active intervention [8].

First-line pharmacotherapy combines an alpha-blocker (tamsulosin, silodosin) for rapid symptom relief with a 5-alpha reductase inhibitor (finasteride, dutasteride) for long-term prostate volume reduction in men with prostates larger than 30 to 40 mL. The CombAT trial (N=4,844) demonstrated that combination therapy reduced clinical progression by 41% compared with tamsulosin monotherapy over 4 years [9]. Adding mirabegron or an antimuscarinic can address persistent storage symptoms once obstruction has been treated, though antimuscarinics carry a small risk of urinary retention in this population [7].

Neurological Conditions That Affect Bladder Control

The bladder is under dual control: the pontine micturition center coordinates voiding, while cortical centers (primarily the frontal lobe) maintain voluntary suppression of the voiding reflex. Damage at any point along this axis can produce neurogenic detrusor overactivity and severe urgency.

Multiple sclerosis (MS) causes lower urinary tract symptoms in 50 to 90% of patients during the disease course [10]. Urgency and urge incontinence are the most common complaints, often preceding the MS diagnosis. Spinal cord lesions above the sacral micturition center (S2 to S4) disrupt the inhibitory signals from the brain, allowing uncontrolled detrusor contractions.

Parkinson disease produces OAB symptoms in approximately 27 to 63.9% of affected individuals, depending on the series [11]. The loss of dopaminergic inhibition in the basal ganglia releases the micturition reflex from tonic suppression. Stroke, particularly involving the frontal cortex or internal capsule, can also produce new-onset urgency in the weeks following the event.

Red flags for neurological causes include bilateral lower-extremity weakness, gait disturbance, saddle-area numbness, bowel incontinence accompanying bladder symptoms, and rapid symptom onset in a patient with no prior urinary complaints. These findings require urgent neurological referral and MRI of the brain and/or spinal cord [10].

The American Urological Association guideline on neurogenic bladder states: "All patients with a known or suspected neurological condition who develop new lower urinary tract symptoms should undergo urodynamic evaluation to characterize the type of bladder dysfunction and guide management" [12].

Interstitial Cystitis and Bladder Pain Syndrome

Interstitial cystitis/bladder pain syndrome (IC/BPS) produces urgency that is driven by pain rather than by involuntary detrusor contraction. Patients describe a persistent or recurrent discomfort perceived in the bladder region, accompanied by urgency and frequency. The key distinguishing feature from OAB is the presence of pain that worsens as the bladder fills and improves after voiding [13].

IC/BPS affects an estimated 3 to 8 million women and 1 to 4 million men in the United States [13]. Diagnosis remains challenging because no single biomarker or test is definitive. The AUA guideline recommends a stepwise approach: first-line treatment includes patient education, dietary modification (avoiding caffeine, alcohol, acidic foods, and artificial sweeteners), and stress management. Pelvic floor physical therapy is recommended as a first-line intervention given evidence that 59% of IC/BPS patients have concomitant pelvic floor dysfunction [14].

Second-line options include oral amitriptyline (10 to 75 mg at bedtime), oral hydroxyzine, and intravesical instillation of dimethyl sulfoxide (DMSO). Pentosan polysulfate sodium (Elmiron), once a mainstay, has fallen from favor after reports linking long-term use to a pigmentary maculopathy that can impair vision, prompting an FDA safety communication in 2020 [15].

Medications and Dietary Triggers

Several prescription drugs can cause or worsen urinary urgency as a side effect. Diuretics (furosemide, hydrochlorothiazide) increase urine production rapidly, overwhelming the bladder's capacity and triggering urgency. Cholinesterase inhibitors used in Alzheimer disease (donepezil, rivastigmine) enhance cholinergic signaling to the detrusor, directly stimulating contraction [16].

Lithium causes nephrogenic diabetes insipidus in up to 40% of patients on chronic therapy, resulting in polyuria and subsequent urgency [17]. SGLT2 inhibitors (empagliflozin, dapagliflozin), prescribed for type 2 diabetes and heart failure, increase glucosuria and urine volume, which may provoke urgency in susceptible individuals.

Caffeine is the most common dietary contributor. A dose-response relationship exists: women consuming more than 329 mg of caffeine per day (roughly three 8-ounce cups of coffee) had a 70% higher odds of detrusor overactivity compared with those consuming less than 100 mg/day in a study of 1,356 women undergoing urodynamics [18]. Alcohol, carbonated beverages, and artificial sweeteners (particularly aspartame) have also been implicated, though evidence is weaker.

A medication reconciliation should be part of every urgency evaluation. Stopping or substituting the offending agent often resolves symptoms without further intervention.

Bladder Stones, Tumors, and Structural Causes

Bladder stones form when urine stasis allows mineral crystallization, most often in the setting of BPH, neurogenic bladder, or chronic catheterization. Stones irritate the bladder wall and trigone, producing urgency, frequency, and sometimes terminal hematuria. Pain that worsens with movement and improves at rest is a characteristic clue [19].

Bladder cancer must be considered in any patient over 40 with new-onset urgency and hematuria (gross or microscopic). Transitional cell carcinoma accounts for roughly 90% of bladder cancers in the United States, and irritative voiding symptoms including urgency are the presenting complaint in approximately 20 to 30% of cases, especially carcinoma in situ (CIS) [20]. CIS can mimic OAB or IC/BPS for months before diagnosis, making cystoscopy with biopsy the definitive test.

Other structural causes include urethral diverticula in women (a pouch that forms along the urethra and can become infected or harbor stones), pelvic organ prolapse compressing the bladder base, and foreign bodies (retained surgical material, migrated mesh). Pelvic imaging with ultrasound or CT and cystoscopy clarify these diagnoses.

Pelvic Floor Dysfunction and Myofascial Pain

The pelvic floor muscles support the bladder, urethra, and (in women) the uterus and vagina. When these muscles are hypertonic (chronically tight), they can refer pain to the bladder and trigger urgency through direct pressure on the trigone or through upregulation of afferent nerve signaling [14].

Pelvic floor hypertonicity is common after childbirth, pelvic surgery, chronic constipation, high-impact exercise, and psychological stress. Patients may report urgency that worsens with prolonged sitting, sexual activity, or stress and improves with warm baths or position changes.

Diagnosis involves a pelvic floor muscle assessment performed by a trained clinician. Treatment with pelvic floor physical therapy focusing on manual trigger-point release, myofascial stretching, and biofeedback relaxation has shown benefit in randomized trials, with symptom improvement in 59 to 80% of patients [14]. This approach is both low-risk and inexpensive, making it a reasonable early intervention even when the contribution of pelvic floor dysfunction is uncertain.

Diagnostic Workup: A Practical Stepwise Approach

The evaluation of urinary urgency does not require expensive or invasive testing in most cases. Start with the basics.

Step 1: Focused history. Ask about onset (acute vs. gradual), associated symptoms (dysuria, hematuria, pain, neurological symptoms), fluid intake patterns, caffeine and alcohol consumption, and a complete medication list. A validated symptom questionnaire such as the OAB-q or IPSS provides a baseline severity score.

Step 2: Urinalysis with culture. This single test rules out infection and screens for hematuria. A clean-catch midstream sample is sufficient.

Step 3: Post-void residual (PVR) measurement. A bladder ultrasound or straight catheterization performed immediately after voiding identifies incomplete emptying. A PVR greater than 200 mL suggests outlet obstruction or detrusor underactivity and changes the management approach [1].

Step 4: Bladder diary. Three consecutive days of recording void times, volumes, fluid intake, urgency episodes, and incontinence events provides objective data that guides treatment intensity.

Step 5 (if indicated): Cystoscopy and urodynamics. Reserve cystoscopy for patients with hematuria, suspected structural pathology, or refractory symptoms. Urodynamic testing (filling cystometry, pressure-flow studies) is indicated when neurogenic bladder is suspected, when surgical intervention is planned, or when the diagnosis remains unclear after initial evaluation [12].

Treatment Options by Cause

Management depends entirely on the underlying etiology. For idiopathic OAB, the AUA/SUFU guideline recommends starting with behavioral therapies: timed voiding, bladder training (gradually increasing the interval between voids by 15 to 30 minutes per week), and pelvic floor muscle exercises [1]. Behavioral interventions alone reduce urgency episodes by 50 to 80% in motivated patients.

When behavioral therapy provides insufficient relief, pharmacotherapy is added. Antimuscarinics (oxybutynin, tolterodine, solifenacin, fesoterodine) block M3 receptors on the detrusor. The STAR trial (N=811) showed that flexible-dose fesoterodine reduced urgency episodes by 72% versus 64% with tolterodine ER over 12 weeks [21]. Side effects include dry mouth, constipation, and (for older agents crossing the blood-brain barrier) cognitive impairment. In adults over 65, the American Geriatrics Society Beers Criteria list strongly anticholinergic drugs as potentially inappropriate [22].

Mirabegron, a beta-3 adrenergic agonist, offers an alternative with a lower anticholinergic side-effect burden. The SCORPIO trial (N=1,978) demonstrated that mirabegron 50 mg reduced mean urgency incontinence episodes from 2.73 to 1.13 per 24 hours versus 1.67 for placebo at 12 weeks [23].

For BPH-driven urgency, alpha-blockers remain first-line. Tamsulosin 0.4 mg daily improves symptom scores within 1 to 2 weeks. For neurogenic detrusor overactivity refractory to oral medications, intradetrusor injection of onabotulinumtoxinA (100 to 200 units) provides a median 6 to 9 months of symptom control per treatment cycle [12].

Sacral neuromodulation (InterStim) and percutaneous tibial nerve stimulation (PTNS) are third-line therapies for refractory OAB. The InSite trial demonstrated that 61% of sacral neuromodulation responders maintained therapeutic success at 5 years [24].

When to Seek Urgent Evaluation

Most urinary urgency is benign. But certain presentations demand prompt medical attention. Gross hematuria (visible blood in the urine) accompanying urgency requires cystoscopy and upper tract imaging to exclude malignancy. New urgency with fever, flank pain, or rigors suggests pyelonephritis or urosepsis and warrants emergency evaluation.

Acute urinary retention (the sudden inability to void despite a full bladder) requires immediate catheterization and urological consultation. And any combination of new urgency with lower-extremity neurological deficits (weakness, numbness, gait changes) should prompt MRI of the spine within 24 hours to rule out cauda equina syndrome or spinal cord compression, both of which are surgical emergencies.

Patients who have tried behavioral modifications and at least one medication for 8 to 12 weeks without adequate improvement should be referred to a urologist or urogynecologist for advanced evaluation including urodynamics and discussion of third-line therapies.